Literature DB >> 32258610

The path toward an HIV-1 vaccine.

Fernando Garces1.   

Abstract

HIV is responsible for millions of deaths around the world and in the absence of available treatment capable of a cure, only the vaccine can offer protection against this virus. However, and after three decades of research, such a vaccine remains elusive. Here, I attempt to explain the major challenges on the development of an anti-HIV immunogen, and how the three-dimensional pictures of antibodies interacting with this virus can guide us to the design of a successful vaccine. Copyright 2017 PBJ-Associação Porto Biomedical/Porto Biomedical Society.

Entities:  

Keywords:  HIV-1 antibodies; HIV-1 trimer structures; HIV-1 virus; Immunogen design; Vaccine

Year:  2017        PMID: 32258610      PMCID: PMC6806768          DOI: 10.1016/j.pbj.2017.06.002

Source DB:  PubMed          Journal:  Porto Biomed J        ISSN: 2444-8664


  16 in total

1.  Variable-loop-deleted variants of the human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits.

Authors:  R W Sanders; L Schiffner; A Master; F Kajumo; Y Guo; T Dragic; J P Moore; J M Binley
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 2.  Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design.

Authors:  Dennis R Burton; Lars Hangartner
Journal:  Annu Rev Immunol       Date:  2016-05-20       Impact factor: 28.527

3.  A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.

Authors:  J M Binley; R W Sanders; B Clas; N Schuelke; A Master; Y Guo; F Kajumo; D J Anselma; P J Maddon; W C Olson; J P Moore
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

5.  Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans.

Authors:  Fernando Garces; Jeong Hyun Lee; Natalia de Val; Alba Torrents de la Pena; Leopold Kong; Cristina Puchades; Yuanzi Hua; Robyn L Stanfield; Dennis R Burton; John P Moore; Rogier W Sanders; Andrew B Ward; Ian A Wilson
Journal:  Immunity       Date:  2015-12-15       Impact factor: 31.745

6.  Structure and immune recognition of trimeric pre-fusion HIV-1 Env.

Authors:  Marie Pancera; Tongqing Zhou; Aliaksandr Druz; Ivelin S Georgiev; Cinque Soto; Jason Gorman; Jinghe Huang; Priyamvada Acharya; Gwo-Yu Chuang; Gilad Ofek; Guillaume B E Stewart-Jones; Jonathan Stuckey; Robert T Bailer; M Gordon Joyce; Mark K Louder; Nancy Tumba; Yongping Yang; Baoshan Zhang; Myron S Cohen; Barton F Haynes; John R Mascola; Lynn Morris; James B Munro; Scott C Blanchard; Walther Mothes; Mark Connors; Peter D Kwong
Journal:  Nature       Date:  2014-10-08       Impact factor: 49.962

Review 7.  Progress toward active or passive HIV-1 vaccination.

Authors:  Amelia Escolano; Pia Dosenovic; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2016-12-21       Impact factor: 14.307

8.  Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice.

Authors:  Amelia Escolano; Jon M Steichen; Pia Dosenovic; Daniel W Kulp; Jovana Golijanin; Devin Sok; Natalia T Freund; Alexander D Gitlin; Thiago Oliveira; Tatsuya Araki; Sarina Lowe; Spencer T Chen; Jennifer Heinemann; Kai-Hui Yao; Erik Georgeson; Karen L Saye-Francisco; Anna Gazumyan; Yumiko Adachi; Michael Kubitz; Dennis R Burton; William R Schief; Michel C Nussenzweig
Journal:  Cell       Date:  2016-09-08       Impact factor: 41.582

9.  HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies.

Authors:  Jon M Steichen; Daniel W Kulp; Talar Tokatlian; Amelia Escolano; Pia Dosenovic; Robyn L Stanfield; Laura E McCoy; Gabriel Ozorowski; Xiaozhen Hu; Oleksandr Kalyuzhniy; Bryan Briney; Torben Schiffner; Fernando Garces; Natalia T Freund; Alexander D Gitlin; Sergey Menis; Erik Georgeson; Michael Kubitz; Yumiko Adachi; Meaghan Jones; Andrew A Mutafyan; Dong Soo Yun; Christian T Mayer; Andrew B Ward; Dennis R Burton; Ian A Wilson; Darrell J Irvine; Michel C Nussenzweig; William R Schief
Journal:  Immunity       Date:  2016-09-08       Impact factor: 31.745

10.  Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein.

Authors:  Javier Guenaga; Fernando Garces; Natalia de Val; Robyn L Stanfield; Viktoriya Dubrovskaya; Brett Higgins; Barbara Carrette; Andrew B Ward; Ian A Wilson; Richard T Wyatt
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.